24×7 Online Assistance Email researchnnnn@gmail.com WhatsApp support Hours 24×7
DM · Super-Speciality (Medical)

Breast & Gynaecological Cancer and Lung Cancer Thesis Topics for DM Medical Oncology — 45+ titles

Updated November 2026 · reviewed against the current NMC / NBE curriculum

Hand-curated database of 45+ DM Medical Oncology (Breast & Gynaecological Cancer and Lung Cancer) dissertation titles, each ready with objectives, synopsis structure and protocol guidance. Unlock the objectives of any title instantly, or get the complete thesis plan — no signup.

45+DM Medical Oncology (Breast & Gynaecological Cancer and Lung Cancer) titles
24×7Instant objectives & thesis plans
100%Plagiarism-free, IEC-ready
Browse all 45 titles See a full thesis plan
Breast & Gynaecological Cancer and Lung Cancer thesis topics

DM Medical Oncology (Breast & Gynaecological Cancer and Lung Cancer) — Thesis Title List

45 titles · instant objectives
  1. 001

    Clinico-pathological profile, receptor status and treatment outcome of breast cancer in young women (below 40 years)

    Breast & Gynaecological Cancer Prospective observational study Prospective Study
    Objective
  2. 002

    Pathological complete response to neoadjuvant chemotherapy in locally advanced breast cancer and its correlation with molecular subtype

    Breast & Gynaecological Cancer Prospective observational study Prospective Study
    Objective
  3. 003

    Cardiotoxicity of trastuzumab and anthracycline-based chemotherapy in HER2-positive breast cancer: incidence and risk factors

    Breast & Gynaecological Cancer Prospective observational study Prospective Study
    Objective
  4. 004

    Outcome of platinum-based chemotherapy in epithelial ovarian cancer and predictors of platinum resistance

    Breast & Gynaecological Cancer Prospective observational study Prospective Study
    Objective
  5. 005

    Concurrent chemoradiation in locally advanced carcinoma cervix: toxicity profile and treatment response

    Breast & Gynaecological Cancer Prospective observational study Prospective Study
    Objective
  6. 006

    Efficacy and toxicity of CDK4/6 inhibitors with endocrine therapy in hormone receptor-positive metastatic breast cancer: a real-world study

    Breast & Gynaecological Cancer Prospective observational study Prospective Study
    Objective
  7. 007

    Clinico-pathological profile and EGFR/ALK mutation status in non-small cell lung cancer and response to targeted therapy

    Lung Cancer Prospective observational study Prospective Study
    Objective
  8. 008

    Clinical profile and outcome of lung cancer in never-smokers compared with smokers

    Lung Cancer Prospective comparative study Comparative Study
    Objective
  9. 009

    Response and survival with immune checkpoint inhibitors in advanced non-small cell lung cancer: a single-centre experience

    Lung Cancer Prospective observational study Prospective Study
    Objective
  10. 010

    Clinical profile, treatment and survival in small cell lung cancer at a tertiary care centre

    Lung Cancer Retrospective record-based study Descriptive Study
    Objective
  11. 011

    Quality of life and symptom burden in patients with advanced lung cancer on systemic therapy

    Lung Cancer Prospective observational study Cross-sectional Study
    Objective
  12. 012

    Ovarian function and fertility preservation practices in young women receiving chemotherapy

    Breast & Gynaecological Cancer Prospective observational study Prospective Study
    Objective
  13. 013

    Clinical profile and outcome of triple-negative breast cancer and role of platinum-based neoadjuvant chemotherapy

    Breast & Gynaecological Cancer Prospective observational study Prospective Study
    Objective
  14. 014

    Pathological complete response with neoadjuvant dual HER2 blockade in HER2-positive early breast cancer: a real-world study

    Breast & Gynaecological Cancer Prospective observational study Prospective Study
    Objective
  15. 015

    Prevalence and clinicopathological features of HER2-low breast cancer compared with HER2-zero breast cancer

    Breast & Gynaecological Cancer Retrospective record-based study Descriptive Study
    Objective
  16. 016

    Prevalence of germline BRCA1 and BRCA2 mutations in triple-negative breast cancer and epithelial ovarian cancer

    Breast & Gynaecological Cancer Hospital-based cross-sectional study Cross-sectional Study
    Objective
  17. 017

    Progression-free survival and toxicity of PARP inhibitor maintenance in BRCA-mutated advanced ovarian cancer

    Breast & Gynaecological Cancer Prospective observational study Prospective Study
    Objective
  18. 018

    Weekly versus three-weekly paclitaxel-carboplatin in advanced epithelial ovarian cancer: response and toxicity

    Breast & Gynaecological Cancer Prospective comparative study Comparative Study
    Objective
  19. 019

    Response and toxicity of pembrolizumab with chemotherapy in recurrent or metastatic carcinoma cervix

    Breast & Gynaecological Cancer Prospective observational study Prospective Study
    Objective
  20. 020

    Molecular classification of endometrial carcinoma by mismatch repair and p53 status and its correlation with outcome

    Breast & Gynaecological Cancer Retrospective record-based study Descriptive Study
    Objective
  21. 021

    Adjuvant capecitabine in triple-negative breast cancer with residual disease after neoadjuvant chemotherapy

    Breast & Gynaecological Cancer Prospective observational study Prospective Study
    Objective
  22. 022

    Clinicopathological profile and treatment outcome of male breast cancer

    Breast & Gynaecological Cancer Retrospective record-based study Descriptive Study
    Objective
  23. 023

    Real-world outcomes and patterns of progression with first-line osimertinib in EGFR-mutant non-small cell lung cancer

    Lung Cancer Prospective observational study Prospective Study
    Objective
  24. 024

    Response and toxicity of low-dose nivolumab with chemotherapy in advanced non-small cell lung cancer

    Lung Cancer Prospective observational study Prospective Study
    Objective
  25. 025

    Concordance between plasma ctDNA and tissue testing for EGFR mutations in advanced non-small cell lung cancer

    Lung Cancer Prospective observational study Diagnostic Study
    Objective
  26. 026

    Outcome of alectinib in ALK-rearranged non-small cell lung cancer at a tertiary care centre

    Lung Cancer Prospective observational study Prospective Study
    Objective
  27. 027

    Indwelling pleural catheter versus talc pleurodesis for malignant pleural effusion in lung cancer

    Lung Cancer Prospective comparative study Comparative Study
    Objective
  28. 028

    CT-defined sarcopenia and its association with chemotherapy toxicity in advanced lung cancer

    Lung Cancer Prospective observational study Prospective Study
    Objective
  29. 029

    Prior empirical antitubercular treatment and diagnostic delay in patients with lung cancer

    Lung Cancer Hospital-based cross-sectional study Cross-sectional Study
    Objective
  30. 030

    Clinical profile and outcome of thymic epithelial tumours

    Lung Cancer Retrospective record-based study Descriptive Study
    Objective
  31. 031

    Prevalence of ESR1 mutations on plasma circulating tumour DNA at progression on aromatase inhibitor plus CDK4/6 inhibitor in hormone receptor-positive metastatic breast cancer

    Breast & Gynaecological Cancer Hospital-based cross-sectional study Cross-sectional Study
    Objective
  32. 032

    Treatment sequencing and outcomes after progression on CDK4/6 inhibitors in hormone receptor-positive HER2-low metastatic breast cancer

    Breast & Gynaecological Cancer Retrospective record-based study Descriptive Study
    Objective
  33. 033

    Response and toxicity of induction chemotherapy followed by concurrent chemoradiation in locally advanced carcinoma cervix

    Breast & Gynaecological Cancer Prospective observational study Prospective Study
    Objective
  34. 034

    Stage at diagnosis, prior screening history and treatment delays among women with carcinoma cervix at a tertiary cancer centre

    Breast & Gynaecological Cancer Hospital-based cross-sectional study Cross-sectional Study
    Objective
  35. 035

    Discordance in HER2 status between primary tumour and metastatic biopsy in breast cancer and its effect on eligibility for HER2-low directed therapy

    Breast & Gynaecological Cancer Hospital-based cross-sectional study Cross-sectional Study
    Objective
  36. 036

    Uptake, toxicity and early outcomes of perioperative and adjuvant systemic therapy in resectable non-small cell lung cancer

    Lung Cancer Prospective observational study Prospective Study
    Objective
  37. 037

    Frequency of uncommon EGFR mutations and response to tyrosine kinase inhibitors in non-small cell lung cancer at a tertiary care centre

    Lung Cancer Retrospective record-based study Descriptive Study
    Objective
  38. 038

    Prevalence of KRAS G12C, ROS1, RET and MET exon 14 alterations on next-generation sequencing in EGFR- and ALK-negative non-small cell lung cancer

    Lung Cancer Hospital-based cross-sectional study Cross-sectional Study
    Objective
  39. 039

    Durvalumab consolidation after concurrent chemoradiation in unresectable stage III non-small cell lung cancer: progression-free survival and pneumonitis

    Lung Cancer Prospective observational study Prospective Study
    Objective
  40. 040

    Response, progression-free survival and neutropenia with eribulin in pretreated metastatic breast cancer: triple-negative versus hormone receptor-positive disease

    Breast & Gynaecological Cancer Prospective observational study Prospective Study
    Objective
  41. 041

    Low-dose lapatinib with capecitabine in trastuzumab-pretreated HER2-positive metastatic breast cancer: response, toxicity and cost

    Breast & Gynaecological Cancer Prospective observational study Prospective Study
    Objective
  42. 042

    Pattern and timing of recurrence by molecular subtype after curative treatment of non-metastatic breast cancer

    Breast & Gynaecological Cancer Retrospective record-based study Descriptive Study
    Objective
  43. 043

    Tumour budding and its association with nodal status, molecular subtype and pathological response to neoadjuvant chemotherapy in breast carcinoma

    Breast & Gynaecological Cancer Prospective observational study Prospective Study
    Objective
  44. 044

    Uptake and yield of visual inspection with acetic acid and clinical breast examination among community health workers offered workplace screening

    Breast & Gynaecological Cancer Cross-sectional study Cross-sectional Study
    Objective
  45. 045

    Baseline pulmonary function and DLCO as predictors of radiation pneumonitis after concurrent chemoradiation in stage III non-small cell lung cancer

    Lung Cancer Prospective observational study Prospective Study
    Objective

DM Medical Oncology (Breast & Gynaecological Cancer and Lung Cancer) thesis — frequently asked questions

How many DM Medical Oncology (Breast & Gynaecological Cancer and Lung Cancer) thesis topics are listed here?

45+ DM Medical Oncology (Breast & Gynaecological Cancer and Lung Cancer) thesis topics are listed on this page, organised by subsection of the Medical Oncology (Breast & Gynaecological Cancer and Lung Cancer) curriculum. Click "Get Objectives" on any title to unlock its aim, objectives and hypothesis instantly.

Do these Medical Oncology (Breast & Gynaecological Cancer and Lung Cancer) topics include the objective and synopsis?

Yes. "Get Objectives" unlocks the research question, aim, primary and secondary objectives, hypothesis and outcome measures. "Full Plan" unlocks the complete synopsis: introduction, review of literature search terms, methodology, sample-size calculation, statistical plan, ethics and timeline — ready to download as Word or PDF.

Are these topics suitable for DNB, DM and FCPS Medical Oncology (Breast & Gynaecological Cancer and Lung Cancer) candidates?

Yes — these Medical Oncology (Breast & Gynaecological Cancer and Lung Cancer) dissertation titles are aligned with NMC, NBE and DNB Medical Oncology (Breast & Gynaecological Cancer and Lung Cancer) curricula and are suitable for DM Medical Oncology (Breast & Gynaecological Cancer and Lung Cancer), DNB Medical Oncology (Breast & Gynaecological Cancer and Lung Cancer) and FCPS candidates alike. We can also tailor a title to your institution's preferred study design.

Can you help with synopsis writing, protocol, data analysis and journal publication?

Yes. Beyond topic selection we provide end-to-end support: synopsis writing (NMC / NBE format), IEC / IRB-ready protocol drafting, data collection forms, statistical analysis (SPSS / R / STATA), full thesis writing, plagiarism check (Turnitin), and journal publication assistance (SCOPUS, UGC-CARE, PubMed-indexed).

How fast can I get the objective for a topic?

Instantly. After payment, the objectives open on screen in under a minute and the full plan in 1–3 minutes, 24×7. You can also click "WhatsApp" on any title to talk to our team.

WhatsApp